Clinical trial
Predictive Factors of 2-year Visual Outcome in Retinal Vein Occlusion Following Intravitreal Ranibizumab Treatment
NCT01968616 is registered in ClinicalTrials.gov with Kyoto University, Graduate School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Factors of 2-year Visual Outcome in Retinal Vein Occlusion Following Intravitreal Ranibizumab Treatment
- Lead sponsor
- Kyoto University, Graduate School of Medicine
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2013
- Completion date
- September 30, 2019
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
macular edema due to brvo/crvo